Clinical Trial Information A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis Protocol Number: 13407 Status: Open Age Group: Adult Treatment Type: Treatment Secondary Protocol No.: RIN-PF-301 Phase: III NCT ID: NCT04708782 Scope Information Scope: National Disease Site(s): Other
